Concepedia

Inhibition of angiogenesis in human endothelial cell using VEGF specific nanobody

Fatemeh Kazemi‐Lomedasht, Mahdi Behdani, Kamran Pooshang Bagheri, Mahdi Habibi‐Anbouhi, Mohsen Abolhassani, Roghaye Arezumand, Delavar Shahbazzadeh, Hasan Mirzahoseini

Molecular Immunology · 2015 · 68 citations · 17 references

DOI

Concepts

References

17

Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer

Herbert I. Hurwitz, Louis Fehrenbacher, William Novotny et al. · New England Journal of Medicine · 2004 · 11K citations · Full text

, , +15

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab

Nicholas Papadopoulos, Joel Martin, Qin Ruan et al. · Angiogenesis · 2012 · 1K citations · Full text

, , +15

Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay

J. David Beatty, Barbara Beatty, William G. Vlahos · Journal of Immunological Methods · 1987 · 626 citations

, , +11

Camelid immunoglobulins and nanobody technology

Serge Muyldermans, Toya Nath Baral, V. Cortez Retamozzo et al. · Veterinary Immunology and Immunopathology · 2008 · 539 citations · Full text

, , +14

Comparison of Bevacizumab, Ranibizumab, and Pegaptanib In Vitro: Efficiency and Possible Additional Pathways

Alexa Klettner, Johann Roider · Investigative Ophthalmology & Visual Science · 2008 · 186 citations

, , +16